XNAS: MIRM
Mirum Pharma Inc Live Stock Price Today, Share Analysis and Chart
about
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestat...
Read More
118.51
1.15
(0.98%)
128.6K
XNAS Volume
XNAS 17 Jul, 2026 11:58 AM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution
View Similar
Embed DVM
Mirum Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..